|4Jul 18, 4:32 PM ET

Gruber James R. 4

4 · Eton Pharmaceuticals, Inc. · Filed Jul 18, 2022

Insider Transaction Report

Form 4
Period: 2022-07-12
Gruber James R.
Chief Financial Officer
Transactions
  • Award

    Restricted Stock Units

    2022-07-12+40,00040,000 total
    Common Stock (40,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock.
  • [F2]The restricted stock units vest in four equal annual installments beginning July 12, 2023, contingent upon the reporting person being employed by the issuer on the date(s) of vesting.

Documents

1 file
  • 4
    ownership.xmlPrimary